Follicular Lymphoma

Showing NaN - NaN of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in United States (JCAR017 (lisocabtagene

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • JCAR017 (lisocabtagene maraleucel) single-dose schedule
  • JCAR017 (lisocabtagene maraleucel) 2-dose schedule
  • Birmingham, Alabama
  • +24 more
Nov 21, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Follicular Lymphoma Trial in United States (Rituximab, Utomilumab, Avelumab)

Active, not recruiting
  • Follicular Lymphoma
  • Duarte, California
  • +5 more
Mar 17, 2022

CLL/SLL, NHL, MCL Trial in United States (HMPL-760)

Recruiting
  • CLL/SLL
  • +8 more
  • Atlanta, Georgia
  • +3 more
Feb 24, 2022

Follicular Lymphoma, Small Lymphocytic Lymphoma, Marginal Zone Lymphoma Trial in United States (dietary supplement, biological,

Active, not recruiting
  • Follicular Lymphoma
  • +3 more
  • Vitamin D
  • +2 more
  • Miami, Florida
  • +6 more
Mar 6, 2022

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Atlanta (Thymoglobulin,

Terminated
  • Acute Leukemia
  • +11 more
  • Thymoglobulin
  • +2 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Mar 30, 2018

Lymphoma, B-Cell, Follicular Lymphoma Trial in Atlanta (Bortezomib, Rituximab, Doxorubicin)

Completed
  • Lymphoma, B-Cell
  • Follicular Lymphoma
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Sep 21, 2016

Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in United States (AT-101)

Completed
  • Follicular Lymphoma
  • +4 more
  • Birmingham, Alabama
  • +10 more
Jun 24, 2011

B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)

Completed
  • B-Cell Lymphoma
  • +2 more
  • VELCADE and rituximab
  • Los Angeles, California
  • +12 more
Feb 7, 2008